Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNA7 | P36544 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | LSS | P48449 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3840605 | 1.00 | CHRNA7 (0.50) | CHRNA7ALDH1A1CHRM2CHRM1CHRM3 | |
| SCHEMBL3842246 | 0.91 | CHRNA7 (0.50) | CHRNA7ALDH1A1CHRM2CHRM1CHRM3 | |
| SCHEMBL3842249 | 0.91 | CHRNA7 (0.50) | CHRNA7ALDH1A1CHRM2CHRM1CHRM3 | |
| SCHEMBL3842109 | 0.88 | TSHR (0.45) | CHRNA7CHRM2CHRM1CHRM3TSHR | |
| SCHEMBL3842111 | 0.88 | TSHR (0.45) | CHRNA7CHRM2CHRM1CHRM3TSHR | |
| SCHEMBL3842653 | 0.86 | CHRNA7 (0.50) | CHRNA7ALDH1A1CHRM2CHRM1CHRM3 | |
| SCHEMBL3842656 | 0.86 | CHRNA7 (0.50) | CHRNA7ALDH1A1CHRM2CHRM1CHRM3 | |
| SCHEMBL3840297 | 0.84 | GAA (0.44) | CHRNA7CHRM2CHRM1CHRM3GAA | |
| SCHEMBL3840299 | 0.84 | GAA (0.44) | CHRNA7CHRM2CHRM1CHRM3GAA | |
| SCHEMBL999950 | 0.84 | CHRNA7 (0.50) | CHRNA7ALDH1A1CHRM2CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9012451-B2 | Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists | NOVARTIS AG (CH) | 2015-04-21 | — | — | US | claimed |
| EP-1537104-B1 | AZA-BICYCLOALKYL ETHERS AND THEIR USE AS ALPHA7-NACHR AGONISTS | NOVARTIS AG (CH) | 2009-11-11 | — | — | EP | claimed |
| US-9012451-B2 | Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists | NOVARTIS AG (CH) | 2015-04-21 | — | — | US | disclosed |
| US-9012451-B2 | Aza-bicycloalkyl ethers and their use as ALPHA7-nachr agonists | NOVARTIS AG (CH) | 2015-04-21 | — | — | US | disclosed |